Background: Vitiligo is an acquired depigmenting disorder with considerable psychosocial burden despite being medically benign. Visible depigmentation, especially on exposed sites, can lead to stigma, anxiety, depression, and reduced quality of life.
Aim: To review psychological impacts of vitiligo, identify risk factors for poor psychosocial outcomes, and present an integrated medical and psychosocial management approach.
Materials & Methods: Narrative review and proposed observational study framework: adult patients with vitiligo attending dermatology clinics are assessed using validated scales (Dermatology Life Quality Index — DLQI, Hospital Anxiety and Depression Scale — HADS) plus clinical evaluation. Management combines medical therapies (topical, phototherapy, systemic, procedural), camouflage, and formal psychological interventions.
Results (expected/templated): High proportion of patients report impaired quality of life; younger age at onset, female gender, lesions on face/hands, and social factors (marriage prospects, employment) correlate with worse scores. Combined dermatologic treatment with psychological support improves adherence and QoL.
Conclusion: Effective vitiligo care requires simultaneous attention to skin repigmentation and psychosocial health — integrate counselling, screening for mood disorders, support groups, and tailored medical therapy.